AC-ARG-ARG-TRP-TRP-CYS-ARG- NH2
中文名称 | AC-ARG-ARG-TRP-TRP-CYS-ARG- NH2 |
---|---|
中文同义词 | 趋化因子受体 (CXCR) 抑制剂多肽IL-8 INHIBITOR |
英文名称 | AC-ARG-ARG-TRP-TRP-CYS-ARG-NH2 |
英文同义词 | IL-8 INHIBITOR;AC-ARG-ARG-TRP-TRP-CYS-ARG-NH2;AC-RRWWCR-NH2;IL-8 Inhibitor, Antileukinate;L-Argininamide, N2-acetyl-L-arginyl-L-arginyl-L-tryptophyl-L-tryptophyl-L-cysteinyl- |
CAS号 | 138559-60-1 |
分子式 | C45H66N18O7S |
分子量 | 1003.19 |
EINECS号 | |
相关类别 | 标准品 |
Mol文件 | 138559-60-1.mol |
结构式 | ![]() |
AC-ARG-ARG-TRP-TRP-CYS-ARG- NH2 性质
密度 | 1.52±0.1 g/cm3(Predicted) |
---|---|
储存条件 | -15°C |
溶解度 | DMF:1mg/mL; DMSO:5mg/mL; PBS(pH 7.2):2 mg/mL |
形态 | 固体 |
酸度系数(pKa) | 9.16±0.10(Predicted) |
Antileukinate inhibits the binding of human eotaxin to human eosinophils with an IC
50
of 8.2 μM.
Antileukinate (10-100 μM; 2 hours) significantly suppresses eosinophil chemotaxis to human eotaxin.
Antileukinate (52.63 mg/kg; s.c.) protectes mice against acute pancreatitis and associated lung injury.
Antileukinate (5mg/kg; s.c.) inhibits the interaction between murine eotaxin and murine eosinophil.
Animal Model: | Swiss mice (20-25g) |
Dosage: | 52.63 mg/kg |
Administration: | Subcutaneous injection |
Result: | Reduced pancreatic edema induced by Caerulein (50 μg/kg). |